CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 70 enrolled
Drug / intervention
Proton Beam Radiationradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00592293
NCT00592293N/ACompleted
CompareCT.gov

Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas

Massachusetts General Hospital·interventional·Posted Jan 14, 2008·Updated Jul 3, 2025

In Brief

A clinical study evaluating Proton Beam Radiation for Non-rhabdomyosarcoma Soft Tissue Sarcoma and Bone Sarcoma. Completed, enrolled 70 participants across 2 sites.

Detailed Summary

The main purpose of this study is to assess the short term and the long term side effects of proton beam radiation for pediatric bone and non-rhabdomyosarcoma soft tissue sarcomas.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNon-rhabdomyosarcoma Soft Tissue Sarcoma, Bone Sarcoma
CountriesUnited States
CollaboratorsBrigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, National Institutes of Health (NIH)

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 14, 2008
Enrollment StartOct 24, 2006
Primary CompletionOct 1, 2016
TodayJul 2, 2026
Enrollment to primary: 9.9 yearsPosted 18.5 years ago

Interventions

Proton Beam Radiationradiation

Once per day, 5 days a week for a total of 4 to 6 weeks.